Analysts on Wall Street project that Travere Therapeutics (TVTX) will announce quarterly loss of $0.58 per share in its forthcoming report, representing an increase of 50$73.44 million, increasing 63% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 9.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this ...